+1-518-618-1030 866 - 552 - 3453 USA-Canada Toll Free

Prescription Arthritis Treatments Market - Singapore and Indonesia, Size, Growth and Industry Analysis

Pre Book Price: $ 5216

Original Price: $ 5795

TABLE OF CONTENT

 

1. INTRODUCTION

1.1. Key Points Covered

1.2. Report Description

1.3. Research Methodology

 

2. EXECUTIVE SUMMARY

 

3. PRESCRIPTION ARTHRITIS TREATMENTS MARKET - SINGAPORE AND INDONESIA

3.1. Market Overview

3.2. Market Trends and Future Outlook

3.3. Macroeconomic Environment

3.4. Growth Drivers

3.5. Market challenges

3.6. Opportunities

3.7. Driving Factor Analysis of Prescription Arthritis Treatments Market

      3.7.1. Demand Side Drivers

      3.7.2. Supply Side Drivers

      3.7.3. Restraints

      3.7.4. Opportunities

      3.7.5. Key Competitive Points

 

4. PRESCRIPTION ARTHRITIS TREATMENTS MARKET BY TYPE

4.1. Overview

4.2. Local Joint Disorder Function 

      4.2.1. Etiology and Pathogenesis

      4.2.2. Clinical Manifestations

4.3. Osteoarthritis

      4.3.1. Etiology and Pathogenesis

      4.3.2. Clinical Manifestations

      4.3.3. Treatment

4.4. Infectious Arthritis

      4.4.1. Etiology and Pathogenesis

      4.4.2. Clinical Manifestations

      4.4.3. Systemic Disorders of Joint Function

4.5. Rheumatoid Arthritis

      4.5.1. Etiology and Pathogenesis

      4.5.2. Clinical Manifestations

4.6. Ankylosing Spondylitis

      4.6.1. Clinical Manifestations

4.7. Psoriatic Arthritis

      4.7.1. Clinical Manifestations

4.8. Enteropathic Arthritis

      4.8.1. Clinical Manifestations

4.9. Adult Onset Still Disease

      4.9.1. Clinical Manifestations

4.10. Juvenile Rheumatoid Arthritis

       4.10.1. Clinical Manifestations

4.11. Still Disease

4.12. Polyarticular Onset

 

5. NON-STEROIDAL ANTI-INFLAMMATORY DRUG MARKET

5.1. Product Description

5.2. Market Forecast and Growth

 

6. DISEASE-MODIFYING ANTI-RHEUMATIC DRUG TREATMENT MARKETS

6.1. Product Descriiption

      6.1.1. Sulfasalazine (Azulfidine-Pfizer)

      6.1.2. Gold Compounds

      6.1.3. Penicillamine (Cuprimine-Merck)

      6.1.4. Chloroquine (Aralen-Sanofi-Aventis)

      6.1.5. Methotrexate (Trexall-Duramed; Rheumatrex-DAVA Pharmaceuticals)

      6.1.6. Leflunomide (Arava-Sanofi-Aventis)

6.2. Market Forecast and Growth

 

7. BIOLOGICAL RESPONSE MODIFIERS AND IMMUNOSUPPRESSIVE DRUG MARKETS

7.1. Description

7.2. Tumor Necrosis Factor

7.3. Glucocorticoids

7.4. Azathioprine (Azasan-Salix)

7.5. Adalimumab (Humira-Abbott)

7.6. Anakinra (Kineret-Amgen)

7.7. Basiliximab (Simulect-Novartis)

7.8. Daclizumab (Zenapax-Roche)

7.9. Etanercept (Enbrel-Amgen)

7.10. Infliximab (Remicade-Janssen Biotech)

7.11. Rituximab (Rituxan-Biogen Idec)

7.12. Abatacept (Orencia-Bristol-Myers Squibb)

7.13. Market forecast and Growth

 

8. ARTHRITIS RESEARCH AND DEVELOPMENT TREATMENTS

8.1. Overview

8.2. Duexis

8.3. Gel-One

8.4. ACZ

8.5. Apremilast

8.6. Fostamatinib

8.7. Lodotra

8.8. Stelara

8.9. Tofacitinib

 

9. COMPETITIVE LANDSCAPE

9.1. Summary

9.2. Market share by key players

9.3. New product launch

9.4. Agreements and collaborations

9.5. Mergers and acquisitions

9.6. Competitive strategy by key players

 

10. GEOGRAPHIC ANALYSIS

10.1. Singapore

        10.1.1. Market Overview and Analysis

        10.1.2. Market Share by Key Players

        10.1.3. Growth Drivers

        10.1.4. Restraints

        10.1.5. Opportunities

10.2. Indonesia

        10.2.1. Market Overview and Analysis

        10.2.2. Market Share by Key Players

        10.2.3. Growth Drivers

        10.2.4. Restraints

        10.2.5. Opportunities

 

11. RECOMMENDATIONS

11.1. Market Strategy for Success

11.2. Barriers to be Considered

11.3. Future Assumptions

 

12. COMPANY PROFILES

12.1. Abbott Laboratories

12.2. Amgen, Inc

12.3. Bristol-Myers Squibb

12.4. Novartis International AG

12.5. Pfizer, Inc.

12.6. Roche

12.7. Regeneron

12.8. UCB

12.9. Others

Singapore and Indonesia Prescription Arthritis Treatments Market: Overview 

Arthritis is becoming an extremely common problem in the world today. Although it is commonly used to describe joint pain, there are over 100 different types of arthritis spread across several categories and sub-categories. Arthritis is also not gender dependent; it can happen to anyone and is often a result of negative lifestyle choices. It is a chronic illness that is affecting a large percentage of the geriatric demographic and is highly prevalent in developed economies. Arthritis is in fact one of the leading chronic illnesses affecting the population of the U.S. From the economic perspective, arthritis has an extremely negative impact as it not only impairs able citizens, but also significantly increases the cost to healthcare services. Studies show that close to half of the patients suffering from arthritis are unable to undertake full-time jobs, causing a severe dent in the economic growth rate. 

The report focuses on the markets for prescription arthritis treatments that exist in Singapore and Indonesia. The two regions have shown a massive increase in their demand for arthritis treatments, boosting the pharmaceutical industry’s production rate of prescription drugs for arthritis. Researchers have taken special steps to ensure an all-encompassing report that covers both nations and the current state of prescription arthritis treatments. Based on these current statistics and the ones from the recent past and the trends that are visible, the report provides a pinpoint forecast for the Singapore and Indonesia prescription arthritis treatments market for the coming years. 

Singapore and Indonesia Prescription Arthritis Treatments Market: Trends and Opportunities: 

The primary factor driving the Singapore and Indonesia prescription arthritis treatments market is the growing percentage of the geriatric demographic. The elderly are highly prone to arthritis of all types and therefore generally form the leading population segment that is in need of arthritis treatments and therapeutics. The number of elderly in Singapore and Indonesia is not only increasing, but advancements in healthcare outreach have contributed to a greater overall population to be studied and treated. 

Furthermore, the Singapore and Indonesia prescription arthritis treatments market is also expected to benefit heavily from the growing number of international players paying attention to the Asia Pacific pharmaceutical industry. This increasing number of players, coupled with a growth in the number of innovations and developments occurring in arthritis-based pharmaceuticals, Singapore and Indonesia are expected to show a steady growth rate in their demand for prescription arthritis treatments. 

Singapore and Indonesia Prescription Arthritis Treatments Market: Region-wise Outlook: 

Both Singapore and Indonesia show a very high proportion of people suffering from rheumatoid arthritis over other types of arthritis. The matter can be further complicated in Indonesia due to high disparities in the national age structure and the high prevalence of other infections. These complications are creating a heavy need for advanced treatments and prescription drugs for arthritis in Singapore and Indonesia. Apart from that, there are also organizations such as the National Arthritis Foundation in Singapore that combat arthritis through increasing awareness and promoting a better level of physical health. 

Companies Mentioned in the Research Report: 

Numerous players already exist in the Singapore and Indonesia prescription arthritis treatments market. At the top of the charts are a number of companies that are either globally prominent entities that bring with them high brand value and recognition, and local players that have established themselves long age. This list of key players includes Abbott Laboratories, Amgen, Inc, Bristol-Myers Squibb, Novartis International AG, Pfizer, Inc., Roche, Regeneron, and UCB. 

Key segments of the Singapore and Indonesia Prescription Arthritis Treatments Market: 

Singapore and Indonesia Prescription Arthritis Treatments Market, by Type:

  • Local Joint Disorder Function
  • Osteoarthritis
  • Infectious Arthritis
  • Rheumatoid Arthritis
  • Ankylosing Spondylitis
  • Psoriatic Arthritis
  • Enteropathic Arthritis
  • Adult Onset Still Disease
  • Juvenile Rheumatoid Arthritis
  • Still Disease
  • Polyarticular Onset 

Major regions analyzed under this research report are:

  • Singapore
  • Indonesia 

This report gives you access to decisive data such as:

  • Market growth drivers
  • Factors limiting market growth
  • Current market trends
  • Market structure
  • Market projections for the coming years 

Key highlights of this report

  • Overview of key market forces propelling and restraining market growth
  • Up-to-date analyses of market trends and technological improvements
  • Pin-point analyses of market competition dynamics to offer you a competitive edge
  • An analysis of strategies of major competitors
  • An array of graphics and SWOT analysis of major industry segments
  • Detailed analyses of industry trends
  • A well-defined technological growth map with an impact-analysis
  • Offers a clear understanding of the competitive landscape and key product segments 

 


To receive discount, please click on the button below.

Please click on the button below to customize this report.

 
 
Back To Top